On Monday, BioAffinity Technologies Inc (NASDAQ: BIAF) was -20.44% drop from the session before settling in for the closing price of $0.37. A 52-week range for BIAF has been $0.26 – $3.16.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 13156.86% over the past five years. When this article was written, the company’s average yearly earnings per share was at 24.18%. With a float of $9.42 million, this company’s outstanding shares have now reached $13.42 million.
Let’s look at the performance matrix of the company that is accounted for 75 employees. In terms of profitability, gross margin is 31.85%, operating margin of -89.13%, and the pretax margin is -90.01%.
BioAffinity Technologies Inc (BIAF) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward BioAffinity Technologies Inc stocks. The insider ownership of BioAffinity Technologies Inc is 39.53%, while institutional ownership is 3.44%.
BioAffinity Technologies Inc (BIAF) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.18% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.34% during the next five years compared to -19.28% drop over the previous five years of trading.
BioAffinity Technologies Inc (NASDAQ: BIAF) Trading Performance Indicators
You can see what BioAffinity Technologies Inc (BIAF) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.66 in one year’s time.
Technical Analysis of BioAffinity Technologies Inc (BIAF)
BioAffinity Technologies Inc (NASDAQ: BIAF) saw its 5-day average volume 0.5 million, a positive change from its year-to-date volume of 0.23 million. As of the previous 9 days, the stock’s Stochastic %D was 33.09%. Additionally, its Average True Range was 0.09.
During the past 100 days, BioAffinity Technologies Inc’s (BIAF) raw stochastic average was set at 2.39%, which indicates a significant decrease from 8.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 180.78% in the past 14 days, which was higher than the 109.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6775, while its 200-day Moving Average is $1.4734. Nevertheless, the first resistance level for the watch stands at $0.3429 in the near term. At $0.3939, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.4247. If the price goes on to break the first support level at $0.2611, it is likely to go to the next support level at $0.2303. Assuming the price breaks the second support level, the third support level stands at $0.1793.
BioAffinity Technologies Inc (NASDAQ: BIAF) Key Stats
There are 15,585K outstanding shares of the company, which has a market capitalization of 4.55 million. As of now, sales total 2,530 K while income totals -7,940 K. Its latest quarter income was 2,350 K while its last quarter net income were -2,000 K.
